Site Members can sign up for company wide alerts
Lawsuit Overview
June 10, 2026 - An investor in shares of ADMA Biologics, Inc. (NASDAQ: ADMA) filed a lawsuit in the U.S. District Court for the District of New Jersey over alleged violations of Federal Securities Laws by ADMA Biologics, Inc. in connection with certain allegedly false and misleading statements made between August 9, 2024 and March 25, 2026. Ramsey, NJ based ADMA Biologics, Inc., a b...
You must register (for free) or login to view the entire case.
